Table 7.

Clinical Trial.

Compound/Extract	Source	Phase	Participants	Status	Registration Number	Results	Ref.
abnobaVISCUM 900, Mitomycin C	Viscum album var. coloratum, Mitomycin C	III	546	Recruiting	NCT02106572		[82]
abnobaVISCUM Fraxini	Viscum album var. coloratum	I, II	37	Completed	NCT02007005	Indication of a direct anti-tumoral effect	[83]
Broccoli sprout extract	Brassica oleracea var. italica	NA	7	Terminated	NCT01108003	Inhibition of the growth of certain cancers	[84]
Erlotinib, Green tea extract	Erlotinib hydrochloride, Camellia sinensis	II	17	Completed	NCT00088946	Inhibition of any remaining tumor cells and inhibition of the recurrence of bladder cancer	[85]
Fluorescent dye	calcium dye	NA	4	Terminated	NCT02494635	Prediction of the cancer invasiveness	[86]
Green tea catechin extract	Camellia sinensis	II	31	Completed	NCT00666562	Inhibition of the growth of certain cancers	[87]
Urell, Cranberry fruit juice extract, proanthocyanidins	Proanthocyanidins, Vaccinium microcarpum	NA	10	Terminated	NCT03986398	Inhibition of uropathogenic E.col bacteria from adhering to uroepithelial cells	[88]